Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancoast Syndrome × Carboplatin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 683 Lung Neoplasms 297 Ovarian Neoplasms 288 Breast Neoplasms 241 Fallopian Tube Neoplasms 141 Triple Negative Breast Neoplasms 124 Small Cell Lung Carcinoma 124 Neoplasms 120 Squamous Cell Carcinoma of Head and Neck 110 Carcinoma, Ovarian Epithelial 104 Neoplasm Metastasis 73 Head and Neck Neoplasms 68 Endometrial Neoplasms 63 Uterine Cervical Neoplasms 61 Adenocarcinoma of Lung 61 Esophageal Neoplasms 60 Central Nervous System Neoplasms 47 Brain Neoplasms 46 Recurrence 45 Lymphoma, Large B-Cell, Diffuse 42 Prostatic Neoplasms 41 Neuroblastoma 41 Carcinoma 41 Parkinson Disease 4, Autosomal Dominant Lewy Body 38 Urinary Bladder Neoplasms 37 Esophageal Squamous Cell Carcinoma 36 Lymphoma 34 Stomach Neoplasms 31 Carcinoma, Squamous Cell 31 Melanoma 29

Interventions

Cisplatin 3 Surgical Procedures, Operative 2 Radiotherapy 2 durvalumab 1 belinostat 1 Vindesine 1 S 1 (combination) 1 Paclitaxel 1 Nivolumab 1 Mitomycin 1 Fluorouracil 1 Etoposide 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05684276 2025-04-10

DUMAS

Fundación GECP

Phase 2 Recruiting

Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡